|
|
穿支动脉粥样硬化病早期神经功能恶化的相关研究进展
|
Abstract:
在中国，脑血管疾病已然成为致死致残的主要病因，其中尤以缺血性卒中占比最高，约占80%。作为急性缺血性卒中的重要亚型，穿支动脉粥样硬化病(Branch Atheromatous Disease, BAD)在临床上常表现出易发生早期神经功能恶化(early neurological deterioration, END)的特征。鉴于目前尚缺乏针对该疾病明确有效的临床干预措施，患者在发病后长期遗留神经功能障碍甚至死亡的风险显著增高，这不仅构成了临床诊疗的挑战，同时也加重了社会及家庭的负担。本文就急性BAD患者早期神经功能恶化的病理机制、预测指标及临床治疗的最新研究进行综述，以期提高临床医生的认识及为改善患者不良预后提供一定证据。
In China, cerebrovascular disease has become a major cause of death and disability, with ischemic stroke accounting for 80% of the cases. As an important subtype of acute ischemic stroke, Branch Atheromatous Disease (BAD) is clinically susceptible to early neurological deterioration (END). In view of the lack of clear and effective clinical interventions for this disease, the risk of long-term neurological dysfunction and even death is significantly higher, which not only constitutes a challenge for clinical diagnosis and treatment, but also aggravates the burden on the society and the family. In this article, we review the latest research on the pathological mechanisms, predictive indicators and clinical treatments of early neurological deterioration in patients with acute BAD with the aim of raising clinicians’ awareness and providing evidence to improve patients’ prognosis.
| [1] | 王璐, 王健. 穿支动脉粥样硬化病患者早期神经功能恶化的研究进展[J]. 中国卒中杂志, 2023, 18(10): 1191-1195. |
| [2] | Li, S., Wang, L., Liu, B., Zhang, P., Zhang, J., Chen, G., et al. (2024) Clinical and Prognostic Characteristics of Acute Bad-Related Stroke: A Multicenter MRI-Based Prospective Study. Stroke, 55, 2431-2438. https://doi.org/10.1161/strokeaha.124.047688 |
| [3] | Caplan, L.R. (1989) Intracranial Branch Atheromatous Disease: A Neglected, Understudied, and Underused Concept. Neurology, 39, 1246-1246. https://doi.org/10.1212/wnl.39.9.1246 |
| [4] | 周立新, 倪俊. 穿支动脉粥样硬化性疾病的诊治进展[J]. 中国卒中杂志, 2020, 15(12): 1342-1351. |
| [5] | 朱利利, 付胜奇, 胡胜洁, 等. 穿支动脉粥样硬化病患者血清生物标志物水平与早期神经功能恶化的关系[J]. 中华老年心脑血管病杂志, 2024, 26(4): 413-417. |
| [6] | Mizuno, S., Deguchi, I., Takahashi, S., Arai, N., Nakagami, T., Kimura, R., et al. (2024) Factors Affecting Early Neurological Deterioration after Intravenous Alteplase Treatment for Branch Atheromatous Disease. Neurology and Clinical Neuroscience, 13, 57-62. https://doi.org/10.1111/ncn3.12848 |
| [7] | 门雪娇, 陈玮琪, 许玉园, 等. 穿支动脉粥样硬化病中国专家共识[J]. 中国卒中杂志, 2021, 16(5): 508-514. |
| [8] | Huang, Y., Tsai, Y., Lin, L., Weng, H., Lee, J. and Yang, J. (2024) Preliminary Results on Temporal Evolution and Clinical Implications of Atherosclerotic Plaque in Branch Atheromatous Disease after Statin Treatment. Therapeutic Advances in Neurological Disorders, 17, 1-12. https://doi.org/10.1177/17562864241273902 |
| [9] | Ren, B., Tan, L., Song, Y., et al. (2022) Cerebral Small Vessel Disease: Neuroimaging Features, Biochemical Markers, Influencing Factors, Pathological Mechanism and Treatment. Frontiers in Neurology, 13, Article 843953. https://doi.org/10.3389/fneur.2022.843953 |
| [10] | Gao, S., Wu, W., Yang, H. and Gou, Y. (2025) Predictive Factors of Early Neurologic Deterioration in Isolated Pontine Infarction. Annals of Indian Academy of Neurology, 28, 38-42. https://doi.org/10.4103/aian.aian_883_24 |
| [11] | Xu, J., Xu, X., Wang, H., He, L., Liu, Q., Du, Y., et al. (2022) Dual Antiplatelet Therapy Plus Argatroban Prevents Early Neurological Deterioration in Branch Atherosclerosis Disease. Stroke, 53, e19-e20. https://doi.org/10.1161/strokeaha.121.036356 |
| [12] | 干德彪, 李军涛, 刘冰, 等. 全身免疫炎症指数与穿支动脉粥样硬化病患者神经功能恶化的相关性[J]. 中华老年心脑血管病杂志, 2025, 27(1): 72-75. |
| [13] | Ha, S.H., Ryu, J., Bae, J. and Kim, J.S. (2022) Isolated Pontine Infarction versus Pontine Plus Infarction: Prevalence, Pathogenic Mechanism, and Outcomes. Journal of Neurology, 269, 4375-4382. https://doi.org/10.1007/s00415-022-11075-1 |
| [14] | Nam, K., Kwon, H. and Lee, Y. (2023) Infarct Growth Velocity Predicts Early Neurological Outcomes in Single Subcortical Infarction. Scientific Reports, 13, Article No. 4511. https://doi.org/10.1038/s41598-023-31727-0 |
| [15] | Tokuda, K., Hanada, K., Takebayashi, T., Koyama, T., Fujita, T. and Okita, Y. (2022) Factors Associated with Prognosis of Upper Limb Function in Branch Atheromatous Disease. Clinical Neurology and Neurosurgery, 218, Article ID: 107267. https://doi.org/10.1016/j.clineuro.2022.107267 |
| [16] | Huang, Y.C., Lee, J.D., Pan, Y.T., et al. (2022) Perfusion Defects and Collateral Flow Patterns in Acute Small Subcortical Infarction: A 4D Dynamic MRI Study. Translational Stroke Research, 13, 399-409. https://doi.org/10.1007/s12975-021-00953-x |
| [17] | Shinohara, Y., Kato, A., Kuya, K., Okuda, K., Sakamoto, M., Kowa, H., et al. (2017) Perfusion MR Imaging Using a 3D Pulsed Continuous Arterial Spin-Labeling Method for Acute Cerebral Infarction Classified as Branch Atheromatous Disease Involving the Lenticulostriate Artery Territory. American Journal of Neuroradiology, 38, 1550-1554. https://doi.org/10.3174/ajnr.a5247 |
| [18] | Huang, Y., Weng, H., Lin, L., Lee, J., Yang, J., Tsai, Y., et al. (2024) Redefining Infarction Size for Small-Vessel Occlusion in Acute Ischemic Stroke: A Retrospective Case–control Study. Neurology International, 16, 1164-1174. https://doi.org/10.3390/neurolint16050088 |
| [19] | Men, X., Hu, M., Guo, Z., Li, Y., Zheng, L., Wu, R., et al. (2023) Culprit Plaques of Large Parent Arteries, Rather than Cerebral Small Vessel Disease, Contribute to Early Neurological Deterioration in Stroke Patients with Intracranial Branch Atheromatous Disease. Cerebrovascular Diseases, 53, 88-97. https://doi.org/10.1159/000530371 |
| [20] | Yoshimura, S., Yamaguchi, S. and Matsuo, T. (2025) Abstract WP185: Apparent Thalamostriate Vein and Brush Sign on Susceptibility-Weighted Imaging as Predictors of Infarct Growth at the Lenticulostriate Artery Territory. Stroke, 56. https://doi.org/10.1161/str.56.suppl_1.wp185 |
| [21] | 车惠英, 曲琳卓, 关宏锏. 大脑中动脉穿支供血区单发脑梗死CISS临床分型及LDL-C、超敏-C反应蛋白的关系[J]. 中风与神经疾病杂志, 2019, 36(2): 140-142. |
| [22] | Ninomiya, I., Kanazawa, M., Uemura, M. and Onodera, O. (2020) Elevated Serum Pentraxin 3 Levels Might Predict the Diagnosis of Branch Atheromatous Disease at a Very Early Stage. European Journal of Neurology, 27, 1279-1284. https://doi.org/10.1111/ene.14249 |
| [23] | 汪效松, 张旭, 雷惠新, 等. 急性脑穿支动脉梗死患者血浆纤维蛋白原及D-二聚体浓度测定研究[J]. 中西医结合心脑血管病杂志, 2012, 10(9): 1062-1063. |
| [24] | 刘明月. 胱抑素C和纤维蛋白原对穿支动脉粥样硬化病早期神经功能恶化影响的相关分析[D]: [硕士学位论文]. 承德: 承德医学院, 2024. |
| [25] | Liu, Y., Wang, H., Xu, R., He, L., Wu, K., Xu, Y., et al. (2023) Serum Uric Acid to Serum Creatinine Ratio Predicts Neurological Deterioration in Branch Atheromatous Disease. Frontiers in Neurology, 14, Article 1098141. https://doi.org/10.3389/fneur.2023.1098141 |
| [26] | Deguchi, I. and Takahashi, S. (2023) Pathophysiology and Optimal Treatment of Intracranial Branch Atheromatous Disease. Journal of Atherosclerosis and Thrombosis, 30, 701-709. https://doi.org/10.5551/jat.rv22003 |
| [27] | Duan, H., Yun, H.J., Geng, X. and Ding, Y. (2022) Branch Atheromatous Disease and Treatment. Brain Circulation, 8, 169-171. https://doi.org/10.4103/bc.bc_56_22 |
| [28] | Wang, Y., Wang, Y., Zhao, X., Liu, L., Wang, D., Wang, C., et al. (2013) Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack. New England Journal of Medicine, 369, 11-19. https://doi.org/10.1056/nejmoa1215340 |
| [29] | Ikeda-Sakai, Y., Sasaki, M. and Nakase, T. (2017) Effects with and without Clopidogrel Loading Treatment for Acute Ischemic Cerebrovascular Disease Patients: A Retrospective Cohort Study. Journal of Stroke and Cerebrovascular Diseases, 26, 2901-2908. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.07.010 |
| [30] | Kimura, T., Tucker, A., Sugimura, T., Seki, T., Fukuda, S., Takeuchi, S., et al. (2016) Ultra-Early Combination Antiplatelet Therapy with Cilostazol for the Prevention of Branch Atheromatous Disease: A Multicenter Prospective Study. Cerebrovascular Diseases Extra, 6, 84-95. https://doi.org/10.1159/000450835 |
| [31] | Yamamoto, Y., Nagakane, Y., Makino, M., Ohara, T., Koizumi, T., Makita, N., et al. (2014) Aggressive Antiplatelet Treatment for Acute Branch Atheromatous Disease Type Infarcts: A 12-Year Prospective Study. International Journal of Stroke, 9, E8. https://doi.org/10.1111/ijs.12200 |
| [32] | Johnston, S.C., Amarenco, P., Denison, H., Evans, S.R., Himmelmann, A., James, S., et al. (2020) Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or Tia. New England Journal of Medicine, 383, 207-217. https://doi.org/10.1056/nejmoa1916870 |
| [33] | Liu, B., Zhang, H., Wang, R., Qu, H., Sun, Y., Zhang, W., et al. (2020) Early Administration of Tirofiban after Urokinase-Mediated Intravenous Thrombolysis Reduces Early Neurological Deterioration in Patients with Branch Atheromatous Disease. Journal of International Medical Research, 48, 1-9. https://doi.org/10.1177/0300060520926298 |
| [34] | 梁炳松, 李育英, 张岐平, 等. 替罗非班治疗进展性穿支动脉梗死临床疗效的相关因素[J]. 临床荟萃, 2023, 38(12): 1091-1094. |
| [35] | 陈娜, 杨海华, 吴海威, 等. 静脉溶栓治疗急性穿支动脉闭塞脑梗死的影响因素[J]. 河北医药, 2023, 45(14): 2100-2105. |
| [36] | 肖婷婷. 阿替普酶联合替罗非班治疗穿支动脉闭塞性脑梗死的疗效及安全性分析[J]. 实用妇科内分泌电子杂志, 2020, 7(17): 184-185. |
| [37] | 刘玉月, 刘萍. 替罗非班辅助尿激酶溶栓治疗老年急性穿支动脉型脑梗死患者的临床疗效[J]. 实用中西医结合临床, 2021, 21(15): 93-94. |
| [38] | Alkhiri, A., Almaghrabi, A., Alamri, A., Alturki, F., Salamatullah, H., Alghamdi, B., et al. (2025) Intravenous Thrombolysis in Branch Atheromatous Disease: A Systematic Review and Meta-Analysis (p7-13.017). Neurology, 104. https://doi.org/10.1212/wnl.0000000000211959 |
| [39] | 杨风刚, 张娜, 张振岭, 等. 不同剂量瑞舒伐他汀对穿支动脉粥样硬化相关卒中患者sdLDL-C水平及复发的影响[J]. 中国临床研究, 2022, 35(8): 1046-1050. |
| [40] | 刘相玉, 贾晨雨, 梁彦启. 尤瑞克林联合阿托伐他汀、阿司匹林治疗穿支动脉病变型脑梗死患者的回顾性研究[J]. 北方药学, 2021, 18(10): 72-74. |
| [41] | Huang, Y., Lee, J., Weng, H., Lin, L., Tsai, Y. and Yang, J. (2021) Statin and Dual Antiplatelet Therapy for the Prevention of Early Neurological Deterioration and Recurrent Stroke in Branch Atheromatous Disease: A Protocol for a Prospective Single-Arm Study Using a Historical Control for Comparison. BMJ Open, 11, e054381. https://doi.org/10.1136/bmjopen-2021-054381 |
| [42] | 朱利利. PCSK9抑制剂对穿支动脉粥样硬化病患者早期神经功能恶化的影响[J]. 中华医学杂志, 2023, 103(37): 2940-2946. |
| [43] | 王年臻, 周治平, 肖成业. 依达拉奉右坎醇联合尤瑞克林治疗穿支动脉病变型进展性脑梗死的效果[J]. 药物生物技术, 2023, 30(6): 609-613. |
| [44] | 王鑫丽, 庞萌, 贾帅, 等. 替罗非班联合依达拉奉治疗穿支动脉病变型进展性缺血性脑卒中临床观察[J]. 山东医药, 2021, 61(20): 49-51. |
